Immunosenescence refers to the immune system undergoing a series of degenerative changes with advancing age and is tightly associated with the initiation and progression of cancers. However, the immunosenescence-related genes as critical biomarkers for bladder cancer (BLCA) have not been systematically analyzed. We retrieved the immunosenescence-related genes from the public database and verified their association with hallmarks of immunosenescence based on The Cancer Genome Atlas (TCGA) cohort. Through gene pairing, Lasso, and univariate Cox regression, an 8-gene pair model was constructed to evaluate the overall survival of BLCA, which was then validated in the training cohort ( ), two external validation cohorts ( ; ), and local samples ( ). We also downloaded the clinical information and gene expression matrices of other 32 different cancers from TCGA. The established model showed significant predictive value for the prognosis in 15 cancers ( ). The risk model could also serve as a promising predictor for immunotherapeutic response, which has been verified by the TIDE algorithm ( ), IMvigor210 dataset ( ), and other two datasets correlated with immunotherapy ( ; ). The TCGA dataset, in vitro cell experiments, and pan-cancer analysis displayed that the gene signature was associated with cisplatin sensitivity (
We introduced and recreated a more consistent and effective experimental varicocele rat model by a new clip technique. A total of 40 rats were numbered and randomly assigned to 5 groups of 8 each, including sham surgery (Group I), conventional (Group II) and clip groups with 0.7, 0.8, 0.9 mm gap widths, respectively (Group III, IV, V). All of the rats in each group were sacrificed at 8 weeks after initial surgery, and the rats forming out with less than 1 mm diameter of left spermatic vein or no presence of the pampiniform plexus dilation were excluded from the experimental groups. The left spermatic vein (LSV) diameter, testicular weight, left kidney weight to body weight coefficients, kidney and testicular histology were determined. The baseline mean diameter of the LSV in Group I, II and III was 0.22 ± 0.02, 0.23 ± 0.02 and 0.22 ± 0.03 mm, respectively (P = 0.7504). At 8 weeks after initial surgery, varicocele was successfully created in 6/8 (75%), 7/8 (87.5%), 3/8 (37.5%), 3/8 (37.5%) in GroupII-V, no varicocele was observed in Group I. In Group I, II and III, no pathological changes were observed and the left kidney weight to body weight coefficients showed no significant differences. The diameter of LSV was remarkably increased both in Group II and III compared to Group I (1.72 ± 0.13, 1.57 ± 0.19 and 0.25 ± 0.02, respectively), and Group II and III had a smaller testicular weight than the rats in Group I (1.67 ± 0.05, 1.62 ± 0.06, and 1.92 ± 0.12, respectively). With a new clip technique, surgically inducing varicocele rat model becomes convenient and safe. This appears to improve the effectiveness of the model and this innovation may allow us to further understand the pathophysiology of varicocele.
The proteomic analysis of seminal plasma (SP) is a powerful tool for screening and identifying potential novel biomarkers of male infertility. However, the proteomic composition of seminal extracellular (SE) vesicles in varicocele (VC) is still poorly characterized. The main objective of the present study was to compare the proteome of SEs between infertile men with VC and fertile men without VC and to reveal differentially expressed SEs proteins (DESEPs) that can serve as potential novel biomarkers of VC‐associated infertility. SEs were isolated and purified from SP, and SEs proteins were extracted and labeled with TMT and analyzed by high‐resolution LC‐MS/MS. A total of 1457 proteins were quantitatively identified in these SEs samples. Of these proteins, 175 DESEPs (76 upregulated and 99 downregulated) were identified. Bioinformatics analysis indicated that the molecular functions and biological processes of these DESEPs were involved in metabolism, cell growth and/or maintenance, energy pathways, transport, and cell activation. Among these DESEPs of interest, PGK2 and LGALS3BP were validated by Western blotting. The expression level of the SEs LGALS3BP was also determined by ELISA. A significant positive association was observed between the concentration of SEs LGALS3BP and clinical characteristics. Moreover, receiver operating characteristic (ROC) curve analysis showed that SEs LGALS3BP had better predictive efficacy than seminal LGALS3BP as a potential diagnostic biomarker of VC‐associated infertility. Differences in the SEs protein profiles indicate that DESEPs may serve as potential biomarkers for VC‐associated infertility.
Endocrine-disrupting chemicals (EDCs) are important environmental risk factors for urogenital malignancies, but the shared molecular mechanisms underlying their carcinogenic effects remain poorly understood. Here, we systematically investigated the common pro-tumorigenic mechanisms of 12 prevalent EDCs, including anthracene, benzo[a]pyrene (BaP), bisphenol A, clofenotane, di(2-ethylhexyl) phthalate, diazinon, dibutyl phthalate, glyphosate, malathion, perfluorooctanoic acid, polychlorinated biphenyls, and triclosan, across four urogenital cancers, including bladder cancer (BLCA), renal cell carcinoma (RCC), prostate adenocarcinoma (PRAD), and testicular germ cell tumor (TGCT). By integrating network toxicology and protein–protein interaction analysis, we identified shared hub targets linking EDC exposure to tumor progression. EGFR and CASP3 were identified as core targets in BLCA, EGFR and CASP9 in RCC, and CASP3, ESR1, and EGFR in PRAD, whereas KIT emerged as a broadly relevant target in TGCT. Molecular docking and molecular dynamics simulations supported the stable binding of EDCs to these targets. Among the predicted interactions, BaP showed strong binding affinity for CASP9 (ΔG = −9.8 kcal/mol) and was therefore selected for experimental validation. Analysis of TCGA data showed that elevated CASP9 expression was significantly associated with poorer overall survival in patients with RCC. In 786-O and ACHN cells, chronic exposure to an environmentally relevant concentration of BaP significantly increased CASP9 protein stability without altering its mRNA expression, suggesting post-transcriptional regulation. Collectively, these findings identify shared molecular targets of EDCs across urogenital cancers and provide new mechanistic insight into EDC-driven tumor progression, prioritizing potential biomarkers and therapeutic targets for environmentally related malignancies.